WithdrawnNot Applicable

Clinical Effect of Stellate Ganglion Block on Gastroesophageal Reflux Disease

Stopped: ethical issues

China0Started 2024-01-30

Plain-language summary

The goal of this clinical trial is to explore Clinical Effect of Stellate Ganglion Block on Gastroesophageal Reflux Disease. The main question it aims to answer is: • Can stellate ganglion block improve gastroesophageal reflux symptoms better on the basis of rehabilitation training? Participants will be randomly allocated into the control group or the experimental group, all under rehabilitation treatment, the experimental group will be given Stellate Ganglion Block once a day additionally. The study lasts 20 days for each participant. Researchers will compare the Gastroesophageal Reflux Disease Questionnaire, Pressure pain threshold, Self-Evaluation Questionnaire for Gastroesophageal Reflux Disease, to see if the Stellate Ganglion Block can help improve the symptom.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Gastroesophageal Reflux Disease diagnosis after determination of acid reflux by gastroenterologist, with upper endoscopy and/or impedance-pHmetry, which confirmed esophagitis and/or hiatal hernia. * aged between 18 and 80 years old. * subjects who tolerate cervical movements in sitting position. * stable vital signs. * normal consciousness Exclusion Criteria: * contraindications for stellate ganglion block. * peptic ulcer. * previous or present gastric cancer. * previous gastric surgery. * recent fractures or cervical trauma.

What they're measuring

Gastroesophageal Reflux Disease Questionnaire

Timeframe: day 1 and day 20

Trial details

NCT IDNCT06215742

SponsorZeng Changhao

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04-30

View on ClinicalTrials.gov More Gastroesophageal Reflux Disease trials